|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Endonovo Therapeutics, Inc.
| | | Phone: | (800) 701-1223 | Fax: | (818) 230-9899 | Year Established: | 2008 | Ticker: | ENDV | Exchange: | OTCQB | Main Contact: | Michael Scott Mann, President | | Other Contacts: | Don Calabria, COO Leonard Makowka, M.D., Ph.D., CMO Alan Collier, Chairman & CEO
| | Company Description | Endonovo Therapeutics is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and cell death. Endonovo's Cytotronics™ platform uses our proprietary bioelectronic technology to create next-generation cell therapies and for the production of fully human biomolecules, such as cytokines and growth factors. | |
|
|
|
|
|